ChemFeeds Site Navigation:
Journal Selection:
Search:

99) Personalized Approach to Diffuse Large B-cell Lymphoma (Clinical Cancer Research) Wednesday June 15th 2016


100) Correction: Hydroxychloroquine Inhibits Autophagy to Potentiate Antiestrogen Responsiveness in ER+ Breast Cancer (Clinical Cancer Research) Wednesday June 1st 2016


101) Correction: Hydroxychloroquine Inhibits Autophagy to Potentiate Antiestrogen Responsiveness in ER+ Breast Cancer (Clinical Cancer Research) Wednesday June 1st 2016


102) MACC1 Induces Tumor Progression in Transgenic Mice (Clinical Cancer Research) Wednesday June 1st 2016


103) MACC1 Induces Tumor Progression in Transgenic Mice (Clinical Cancer Research) Wednesday June 1st 2016


104) DNA Ploidy and PTEN/6q15 Deletions in Prostate Cancer (Clinical Cancer Research) Wednesday June 1st 2016


105) DNA Ploidy and PTEN/6q15 Deletions in Prostate Cancer (Clinical Cancer Research) Wednesday June 1st 2016


106) Role of NDUFA4L2 in Clear Cell Renal Cell Carcinoma (Clinical Cancer Research) Wednesday June 1st 2016


107) B7x Immunosuppression in Human Gliomas (Clinical Cancer Research) Wednesday June 1st 2016


108) Dynamic ER Adaptation to AI Therapy (Clinical Cancer Research) Wednesday June 1st 2016


109) Dynamic ER Adaptation to AI Therapy (Clinical Cancer Research) Wednesday June 1st 2016


110) MYD88 Mutations (L265P vs. Other) in DLBCL (Clinical Cancer Research) Wednesday June 1st 2016


111) Cotargeting AR-Vs and mTOR in CRPC (Clinical Cancer Research) Wednesday June 1st 2016


112) Mutant-Specific TCR Gene Therapy Eradicates Cancer (Clinical Cancer Research) Wednesday June 1st 2016


113) MCT4 as a Potential Therapeutic Target for CRPC (Clinical Cancer Research) Wednesday June 1st 2016


114) Antiangiogenic Activity and Toxicity of Itraconazole Isomers (Clinical Cancer Research) Wednesday June 1st 2016


115) Preclinical Study of Evofosfamide and Topotecan (Clinical Cancer Research) Wednesday June 1st 2016


116) Combination of CART19 and Ibrutinib for Mantle Cell Lymphoma (Clinical Cancer Research) Wednesday June 1st 2016


117) PTEN and p4EBP for pCR Prediction (Clinical Cancer Research) Wednesday June 1st 2016


118) Prostate Cancer Correlation of RSI-MRI and Gleason Grade (Clinical Cancer Research) Wednesday June 1st 2016


119) Phase I Study of MK-2206 and Lapatinib in Combination (Clinical Cancer Research) Wednesday June 1st 2016


120) MK-2206 in Advanced Estrogen Receptor-Positive Breast Cancer (Clinical Cancer Research) Wednesday June 1st 2016


121) Hypoxia and Cancer Stem Cells in HPV-Negative HNSCC (Clinical Cancer Research) Wednesday June 1st 2016


122) Lessons Learned for Dose Selection (Clinical Cancer Research) Wednesday June 1st 2016


123) Rendering the 3 + 3 Design to Rest (Clinical Cancer Research) Wednesday June 1st 2016


124) Nonclinical Safety Evaluations of Oncology Drugs (Clinical Cancer Research) Wednesday June 1st 2016


125) Dose Optimization for Small-Molecule Oncology Drugs (Clinical Cancer Research) Wednesday June 1st 2016


126) Phase I Testing: 60 Years in the Making (Clinical Cancer Research) Wednesday June 1st 2016


127) The Role of BRD4 in PI3K Signaling Resistance (Clinical Cancer Research) Wednesday June 1st 2016


128) Neoantigen for Adoptive T-cell Therapy (Clinical Cancer Research) Wednesday June 1st 2016


129) AKT Inhibitors in the Treatment of Cancer (Clinical Cancer Research) Wednesday June 1st 2016


130) Correction: A First-in-Human Phase I Study of the Oral p38 MAPK Inhibitor, Ralimetinib (LY2228820 Dimesylate), in Patients with Advanced Cancer (Clinical Cancer Research) Thursday May 12th 2016


131) The MEK1/2 Inhibitor Pimasertib Enhances Gemcitabine Efficacy--Response (Clinical Cancer Research) Thursday May 12th 2016


132) The MEK1/2 Inhibitor Pimasertib Enhances Gemcitabine Efficacy--Letter (Clinical Cancer Research) Thursday May 12th 2016


133) Prognostic Role of CTCs in Primary Breast Cancer (Clinical Cancer Research) Thursday May 12th 2016


134) Transcriptional Profiling in Colorectal Liver Metastases (Clinical Cancer Research) Thursday May 12th 2016


135) Immune Profile Associated with PDAC Survival (Clinical Cancer Research) Thursday May 12th 2016


136) Cyclin E1 Suppression and Sorafenib Sensitivity in HCC (Clinical Cancer Research) Thursday May 12th 2016


137) CD24-p53 Interaction in Prostate Cancer Progression (Clinical Cancer Research) Thursday May 12th 2016


138) JQ1 and Panobinostat Combination Therapy (Clinical Cancer Research) Thursday May 12th 2016


139) Blocking HSP90 Addiction Delays Osteosarcoma Progression (Clinical Cancer Research) Thursday May 12th 2016


140) Inhibition of Akt/mTORC1 Axis by TRIB3 Pseudokinase (Clinical Cancer Research) Thursday May 12th 2016


141) SIRT1 as a Therapeutic Target in Pancreatic Cancer (Clinical Cancer Research) Thursday May 12th 2016


142) Supp. High-fat Low-Carbohydrate Diet for Glioblastoma (Clinical Cancer Research) Thursday May 12th 2016


143) Targeting MYCN in Neuroblastoma (Clinical Cancer Research) Thursday May 12th 2016


144) CD126 and Chemoresistance (Clinical Cancer Research) Thursday May 12th 2016


145) Common Cancer Drugs do not Impair Imgatuzumab-Mediated ADCC (Clinical Cancer Research) Thursday May 12th 2016


146) mTOR Pathway Mutations and Response to Rapalogs in RCC (Clinical Cancer Research) Thursday May 12th 2016


147) FCGR, Cetuximab, and Colorectal Cancer Survival (Clinical Cancer Research) Thursday May 12th 2016


148) Type IV Collagen in Colorectal Cancer (Clinical Cancer Research) Thursday May 12th 2016


149) An Endothelial Gene Signature in Breast Cancer Patients (Clinical Cancer Research) Thursday May 12th 2016


150) Neoadjuvant Chemotherapy: Expression Changes and Prognosis (Clinical Cancer Research) Thursday May 12th 2016


151) SMARCA4 Is Predictive of Cisplatin Outcomes in NSCLC (Clinical Cancer Research) Thursday May 12th 2016


152) Plasma/Tissue EGFR Analysis from a Phase I Rociletinib Study (Clinical Cancer Research) Thursday May 12th 2016


153) A Novel Pathogenic Germline Variant in Melanoma (Clinical Cancer Research) Thursday May 12th 2016


154) Refametinib and Sorafenib Combination in Advanced Cancer (Clinical Cancer Research) Thursday May 12th 2016


155) Ofatumumab and Lenalidomide for Relapsed CLL (Clinical Cancer Research) Thursday May 12th 2016


156) Cabozantinib Overcomes Clinical Resistance to Crizotinib (Clinical Cancer Research) Thursday May 12th 2016


157) Vaccine-Induced Lesion Clearance Relates to Immune Response (Clinical Cancer Research) Thursday May 12th 2016


158) The Impact of APMs on Oncology Innovation and Patient Care (Clinical Cancer Research) Thursday May 12th 2016


159) IFN{gamma} and PD-L1 Induction in Cancer Immunity (Clinical Cancer Research) Thursday May 12th 2016


160) Neoadjuvant Trials for Drug Development (Clinical Cancer Research) Thursday May 12th 2016


161) Use of mTORC1 Inhibitors Facing Kidney Cancer Heterogeneity (Clinical Cancer Research) Thursday May 12th 2016


162) Therapeutic HPV Vaccine (Clinical Cancer Research) Thursday May 12th 2016


163) Correction: Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type Glioblastomas (Clinical Cancer Research) Sunday May 1st 2016


164) Correction: Cabozantinib Suppresses Tumor Growth and Metastasis in Hepatocellular Carcinoma by a Dual Blockade of VEGFR2 and MET (Clinical Cancer Research) Sunday May 1st 2016


165) Significance of Fc{gamma}RIIIa-V158F Polymorphism--Letter (Clinical Cancer Research) Sunday May 1st 2016


166) Chromatin and Kinase Variants in Paragangliomas (Clinical Cancer Research) Sunday May 1st 2016


167) Somatic Mutations in Relapsed DLBCL (Clinical Cancer Research) Sunday May 1st 2016


168) White Adipose Tissue Inflammation and Breast Cancer (Clinical Cancer Research) Sunday May 1st 2016


169) PDE5 Enhances Breast Cancer Cell Invasive Potential (Clinical Cancer Research) Sunday May 1st 2016


170) Tumor Microenvironment Immune Type in Pan-Cancer (Clinical Cancer Research) Sunday May 1st 2016


171) Strategic PI3K Inhibition for ER+ Breast Cancer (Clinical Cancer Research) Sunday May 1st 2016


172) Identification of an Immunogenic Subset of Uveal Melanoma (Clinical Cancer Research) Sunday May 1st 2016


173) Immune Recognition of Driver Mutations in Lymphoma (Clinical Cancer Research) Sunday May 1st 2016


174) VCN-01 Antisarcoma Effect (Clinical Cancer Research) Sunday May 1st 2016


175) Effect of Polyfunctional Neu T Cells Is TNF{alpha}/IL17 Dependent (Clinical Cancer Research) Sunday May 1st 2016


176) Detection of CTCs by a Novel In Vivo Approach (Clinical Cancer Research) Sunday May 1st 2016


177) Pseudoprogression/Radionecrosis and Kinetic FET-PET (Clinical Cancer Research) Sunday May 1st 2016


178) Inherited Genetics and Exposure to Chemotherapy (Clinical Cancer Research) Sunday May 1st 2016


179) Heterogeneity of PD-L1 (Clinical Cancer Research) Sunday May 1st 2016


180) An Alternative for Patient-Derived Xenograft (Clinical Cancer Research) Sunday May 1st 2016


181) Myeloid DCs Induce Effective Responses in Melanoma Patients (Clinical Cancer Research) Sunday May 1st 2016


182) Evaluation of PF-03446962 in Patients with Solid Tumors (Clinical Cancer Research) Sunday May 1st 2016


183) Afatinib and Nimotuzumab in Non-Small Cell Lung Cancer (Clinical Cancer Research) Sunday May 1st 2016


184) Comparative Oncology in Drug Development (Clinical Cancer Research) Sunday May 1st 2016


185) Optimizing Doses and Schedules of Small Targeted Drugs (Clinical Cancer Research) Sunday May 1st 2016


186) ER Stress, Dendritic Cells, and Cancer Immunity (Clinical Cancer Research) Sunday May 1st 2016


187) Quantifying Treatment Benefit in Molecular Subgroups (Clinical Cancer Research) Sunday May 1st 2016


188) Most Expedited Safety Reports Are Uninformative (Clinical Cancer Research) Sunday May 1st 2016


189) Immunotherapy of Breast Cancer (Clinical Cancer Research) Sunday May 1st 2016


190) Biomarkers for PD-1 Axis Therapies (Clinical Cancer Research) Sunday May 1st 2016


191) Strategic Scheduling of PI3K Inhibitors (Clinical Cancer Research) Sunday May 1st 2016


192) NOTCH1-Driven Cancer Stem Cells in Adenoid Cystic Carcinoma (Clinical Cancer Research) Friday April 15th 2016


193) Implications of DNA Methylation for Renal Cell Cancer Risk (Clinical Cancer Research) Friday April 15th 2016


194) FA Loss Drives Tumor Cell Invasion (Clinical Cancer Research) Friday April 15th 2016


195) CML LSCs Express CD25 (Clinical Cancer Research) Friday April 15th 2016


196) ICR in CSCs Maintains ICAM-1 Expression in HCC (Clinical Cancer Research) Friday April 15th 2016


View: prev | next


Mitch Andre Garcia's Chem Feeds 2008-present

Some images have been reproduced by permission of The Royal Society of Chemistry. (RSC' RSS Policy)
Other images have been reproduced with permission of the American Chemical Society. (ACS' RSS Policy)
Few images have been reproduced with pending permission of Wiley-VCH. ()